Business Context and Reporting Period
Company: TriSalus Life Sciences, Inc. (TLSI)
Filing Type: Form 8-K (Current Report)
Date of Report: March 27, 2025
Reporting Period: Year-ended December 31, 2024
Context: The Company issued a press release on March 27, 2025, providing a business update and announcing financial results for the fiscal year 2024. The Company is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The 8-K serves as a notification that these results were announced in a press release (Exhibit 99.1), which is incorporated by reference but not detailed within the body of this specific document. The financial information referenced is unaudited and subject to change.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the full text of the press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
- Management Commentary: The Company provided a business update alongside the financial results announcement.
- Unusual Items/Contingencies: The filing explicitly states that the financial information is unaudited and subject to change.
- Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 27, 2025) for specific revenue, net income, and cash flow figures.
- Verify the unaudited status of the reported financial data.
- Check for any specific operational updates or strategic shifts mentioned in the business update portion of the press release.
- Confirm the status of the Company's emerging growth company designation and any related accounting standard elections.